Product Images Amlodipine Besylate And Atorvastatin Calcium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 17 images provide visual information about the product associated with Amlodipine Besylate And Atorvastatin Calcium NDC 43598-322 by Dr. Reddy's Laboratories Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

container1 - container1

container1 - container1

container10 - container10

container10 - container10

container11 - container11

container11 - container11

container2 - container2

container2 - container2

container3 - container3

container3 - container3

container4 - container4

container4 - container4

container5 - container5

container5 - container5

container6 - container6

container6 - container6

container7 - container7

container7 - container7

container8 - container8

container8 - container8

container9 - container9

container9 - container9

figure1 - figure1

figure1 - figure1

figure2 - figure2

figure2 - figure2

figure3 - figure3

figure3 - figure3

figure4 - figure4

figure4 - figure4

This is a graph that shows the cumulative hazard for Placebo and Atorvastatin over time. The hazard is measured as the likelihood of experiencing the primary endpoint, which is not specified in the given text. The x-axis represents the time to the first primary endpoint over four years of follow-up, while the y-axis represents the cumulative hazard percentage. Atorvastatin has a lower hazard ratio (HR) than Placebo, 0.63, which is statistically significant with a p-value of 0.001.*

figure5 - figure5

figure5 - figure5

This appears to be a table showing the percentage of subjects who experienced a cardiovascular event while taking either 10mg or 80mg doses of atorvastatin. The HR (hazard ratio) is also listed as 0.78 with a confidence interval, suggesting that the 80mg dose was more effective in reducing the risk of a cardiovascular event, compared to the 10mg dose. Additionally, a graph displays the time to first major cardiovascular endpoint over the span of four years.*

structure - structure

structure - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.